Context
Protein levels in infant formula vary across products. Some formulas contain higher protein concentrations (≥2.5 g per 100 kcal), historically intended to support early growth. Questions have been raised about whether protein intake during infancy may influence growth patterns or later overweight risk.
This Cochrane review evaluated randomized controlled trials comparing higher versus lower protein intake in healthy term infants.
Study Overview
Design: Systematic review and meta-analysis of randomized controlled trials (Cochrane methodology)
Population: 1,885 healthy, full-term, formula-fed infants
Comparison:
High-protein formula (≥ 2.5 g/100 kcal)
Standard-protein formula (1.8–<2.5 g/100 kcal)
Low-protein formula (<1.8 g/100 kcal)
Follow-up: Most trials ≈ 4 months; longest follow-up up to 5–11 years
Funding: All included trials were industry funded
Evidence Certainty (GRADE): Very low to low certainty for most growth and obesity outcomes
Key Findings
No clear difference in weight-for-age during the first year of life.
No consistent difference in height-for-age or weight-for-height.
Uncertain effect on overweight or obesity at 5 years (very low certainty evidence).
Similar rates of reported adverse events across protein levels.
No data on all-cause mortality.
Limitations
High dropout rates in several trials.
Substantial heterogeneity in pooled analyses (I² up to >80%).
Wide confidence intervals encompassing potential benefit and harm.
Most studies had short follow-up durations.
All trials were industry funded.
Neutral Interpretation
The available evidence remains uncertain.
Full Citation
Gonzalez-Garay AG, Serralde-Zúñiga AE, Medina Vera I, et al.
Higher versus lower protein intake in formula-fed term infants.
Cochrane Database of Systematic Reviews. 2023.
PMID: 37929831.
Available via PubMed: https://pubmed.ncbi.nlm.nih.gov/37929831/
Disclosure
This summary is based on the published Cochrane systematic review.
It is provided for informational purposes only and does not constitute medical advice.